News

Keynote Speaker: Prof. Bruce Freeman will introduce Redox Medicine 2024

It is a great pleasure to announce that Prof. Bruce A. Freeman, Irwin Fridovich Distinguished Professor and Chair at the University of Pittsburgh School of Medicine Department of Pharmacology & Chemical Biology, will introduce Redox Medicine 2024 with a key note talk titled "Small Molecule Electrophiles: Lessons from a Journey through Studying the Redox Chemistry of Nitrogen Oxides to Drug Development”.

Professor Freeman will discuss the generation and actions of nitrogen oxide-derived fatty acid nitroalkenes in the context of their cell signaling actions, physiological responses and potential therapeutic effects as synthetic drug candidates.

Contributions of Professor Bruce A. Freeman to Redox Biology

The research conducted by Professor Bruce. Freeman focuses on the study of oxidizing and free radical inflammatory mediators, including superoxide, hydrogen peroxide, nitric oxide (NO), and peroxynitrite, in the context of cellular signaling and disease mechanisms.

Professor Freeman's laboratory has identified important roles for reactive oxygen and nitrogen species in cellular signaling and disease processes. Initial research established the cellular sources of superoxide and hydrogen peroxide. Subsequent work revealed that NO interacts with superoxide to produce reactive nitrogen species, expanding the known functions of NO in cellular signaling beyond the activation of guanylate cyclase.

Additionally, Freeman's research into peroxynitrite, generated by the reaction of NO with superoxide, has highlighted its role in cellular dysfunction and disease. The laboratory's findings on the actions and targets of peroxynitrite have provided insights into the mechanisms of disease previously attributed to its precursor molecules.

Professor Freeman's research has contributed significantly to the understanding of redox biology, particularly in terms of the roles of reactive species in cellular signaling and disease. These contributions have implications for developing therapeutic strategies for diseases related to oxidative stress and inflammation.

Join us at Redox Medicine 2024 this June in Paris and connect with Prof. Freeman!

You can share your studies by submitting an abstract. 

Redox Medicine Society
Redox Medicine 2024 Conference
June 27-28 - Paris, France
Press Releases | Newsletters Archive | LinkedIn 

Dr. Miria Ricchetti: Keynote Speaker of the Second Day of Redox Medicine 2024

It is a great pleasure to welcome Dr. Miria Ricchetti, Institut Pasteur, France, as a keynote speaker of Day 2 of Redox Medicine 2024. 

Dr. Ricchetti, active member of the RMS Scientific Board, will introduce the second day of the conference with a presentation on the Redox Interactome in Physiopathology. 

She is the head and group leader of the laboratory "Molecular Mechanisms of Pathological and Physiological Ageing" at Institut Pasteur. 

More about Dr. Ricchetti.

Redox Medicine 2024 will keep you updated on all redox recent advances. 

Submit an abstract. 

Redox Medicine Society
Redox Medicine 2024 Conference
June 27-28 - Paris, France
Press Releases | Newsletters Archive | LinkedIn

NADH: The Redox Sensor in Aging-Related Disorders

The Redox Medicine Society is pleased to welcome Dr. Roberta Rizzo, Università degli Studi di Ferrara, Italy to the 26th International Conference "Redox Medicine 2024" this June in Paris. 

Title: NADH: The Redox Sensor in Aging-Related Disorders

About Dr. Rizzo
Roberta Rizzo is affiliated with the Department of Chemical, Pharmaceutical, and Agricultural Sciences in Università degli Studi di Ferrara, Italy. She serves as the President of the Council for Research and the Third Mission and holds the position of Vice-Rector for Research.Her latest publication elaborate on NADH as a crucial redox sensor in aging-related disorders, highlighting her expertise in the field.

Redox Medicine 2024 Speaker Line-up.

Redox Medicine Society
Redox Medicine 2024 Conference
June 27-28 - Paris, France
Press Releases | Newsletters Archive | LinkedIn 

Drug Repurposing on Alzheimer's Disease & NRF2 Modulation

Prof. George M. Spyrou, The Cyprus Institute of Neurology & Genetics (CING),Cyprus, will join Redox Medicine 2024 this June to give a presentation on his latest research: "Drug repurposing on Alzheimer's Disease & NRF2 Modulation".

About George M. Spyrou

Prof. George M. Spyrou holds a BSc in Physics, an MSc in Medical Physics, and an MSc in Bioinformatics as well. During his Ph.D., he worked on algorithms and simulations focusing on breast imaging. Since 2017, Dr. Spyrou is the Bioinformatics Course Coordinator at the Postgraduate School of CING where he has been elected as a full Professor in 2019.

He is also a visiting instructor on thematic areas including Systems Bioinformatics, Biological Network Analysis, and Biomedical Informatics in other undergraduate and postgraduate courses. Dr. Spyrou is a Senior IEEE Member and a Member of the Steering Committee for the creation of the European Bioinformatics Infrastructure ELIXIR-Cyprus.

Redox Medicine 2024 Speaker Line-up.

Redox Medicine Society
Redox Medicine 2024 Conference
June 27-28 - Paris, France
Press Releases | Newsletters Archive | LinkedIn